Page last updated: 2024-10-15

tetra(2-n-methylpyridyl)porphine

Description

tetra(2-N-methylpyridyl)porphine: binds with human serum albumin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135431067
SCHEMBL ID450416
MeSH IDM0160778

Synonyms (8)

Synonym
2-tmpyp
tetra(2-n-methylpyridyl)porphine
pyridinium, 2,2',2'',2'''-(21h,23h-porphine-5,10,15,20-tetrayl)tetrakis(1-methyl-
2,2',2'',2'''-(21h,23h-porphine-5,10,15,20-tetrayl)tetrakis(1-methylpyridinium)
meso-tetra(2-n-methylpyridyl)porphine
59728-89-1
SCHEMBL450416
5,10,15,20-tetrakis(1-methylpyridin-1-ium-2-yl)-21,23-dihydroporphyrin

Compound-Compound Interactions

ExcerptReference
" We defined new strategies aimed at treatment of mature established biofilms using photodynamic treatment (PDT) combined with chemotherapy or phagocytosis."( The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms.
Di Poto, A; Provenza, G; Sbarra, MS; Speziale, P; Visai, L, 2009
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]